Researchers are edging closer to something long imagined but never quite within reach: a single vaccine platform that could ...

With President Donald Trump back in the White House in 2025, it’s no surprise that he dominates the FactCheck.org year-end ...

Get the latest Moderna (MRNA) stock analysis: balanced risk-reward, new vaccine launches, and pipeline insights. See why we ...

A Stanford-led study probes why a very small number of people develop heart inflammation shortly after mRNA COVID-19 ...

GC Biopharma (006280.KS), a leading global biopharmaceutical company, announced today that Ministry of Food and Drug Safety (MFDS) in South Korea has approved the Investigational New Drug (IND) ...

Cancer researchers have chased the idea of a universal cancer vaccine for decades. The promise sounds bold and almost ...

This year was marked by the resurgence of the Kennedys, one of America’s dynasties, but in unexpected ways from MAHA to ...

From GLP-1 weight-loss drugs and mRNA cancer vaccines to longevity science and regenerative medicine, 2025 marked a decisive ...

The appointment of a fervent vaccine opponent — Robert F. Kennedy Jr. — as secretary of the Department of Health and Human ...

Momentum traders who seek fast-moving stocks have three to look at. Sandisk (SNDK) gained 15.2% in the last week. It trades ...

From smartphones to artificial intelligence, technology moved from the margins of daily life to its center, transforming how ...

Throughout 2025, CancerVax achieved substantial scientific progress, expanded its leadership and intellectual property portfolio, and advanced the development of its AI-engineered "Smart mRNA" and ...